世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

腸管疾患検査市場：技術別（従来型、迅速型）、エンドユース別（食品（食肉、鶏肉、魚介類、乳製品、加工食品、果物・野菜）、水）、検査対象病原体別、地域別 - 2026年までの世界予測


Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026

腸内細菌検査の世界市場は、2021年には18億米ドルと推定されていますが、今後6.0%のCAGRで成長し、2026年には24億米ドルに達すると予測されています。食中毒は、医療システムや貿易に負担をかけ、社会経済の発展... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2021年8月26日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		274 343 英語

※ 調査会社の事情により、予告なしに価格が変更になる場合がございます。
最新の価格はデータリソースまでご確認ください。
日本語のページは自動翻訳を利用し作成しています。


　

サマリー

腸内細菌検査の世界市場は、2021年には18億米ドルと推定されていますが、今後6.0%のCAGRで成長し、2026年には24億米ドルに達すると予測されています。食中毒は、医療システムや貿易に負担をかけ、社会経済の発展に影響を与えています。腸内細菌検査市場の成長を促している要因は、汚染物質の検出に関する厳格な規制の実施、消費者の意識の高まり、湿度の高い大気環境などであり、これらが食品の汚染を増加させています。食中毒を原因とする腸疾患の問題に対処するためには、各地域の主要プレイヤーは、食品安全監視プログラムをさらに改善する必要があります。

腸管疾患検査市場の最終用途別セグメントでは、食品セグメントが最大の市場シェアを占めると推定されます。
世界の食品貿易は拡大しており、消費者は年間を通じてより多くの種類の食品を入手できるようになっています。貿易の拡大に伴い、食品汚染物質が出現し、各国の食品安全規制や基準の多様性がクローズアップされています。国際貿易の拡大は、食品安全に関するグローバルな義務や規制の必要性を生み出し、これが腸管疾患検査の市場を牽引する重要な要因となっています。

技術別に見ると、腸管疾患検査市場では、迅速技術のセグメントが最も速いシェアを占めると予測されています。

迅速技術は、迅速な結果、高い感度、信頼性など様々な利点があるため、様々な検査会社で広く使用されており、保証付きクレームのメーカーが製品の安全性と品質を提供できるようになりました。クロマトグラフィーやスペクトロメトリーなどの最新技術は、南米やアフリカではあまり採用されていませんが、アジア太平洋地域の国々では、現在の市場リーダーの投資が拡大しているため、採用が増加しています。

予測期間中、腸疾患検査市場の最大のシェアを占めるのは、食品最終用途セグメントの中の食肉・鶏肉・魚介類のサブセグメントであると推定されます。

細菌汚染は食肉処理のすべての段階で発生し、食中毒の原因となります。解凍や皮剥ぎは、動物の不適切な取り扱いや不衛生な環境が原因で、最大の汚染が発生するステージです。不適切な機器の洗浄手順は、製品の二次汚染の原因となっています。そのため、食肉、鶏肉、魚介類の製品では、その検査に対する需要が高まっています。
世界の腸管疾患検査市場では、北米地域が最大の市場シェアを占めると推定されています。

北米地域は、最も先進的な食品安全プログラムを有していると考えられていますが、大きな課題に直面しています。食品の安全性に影響を与える要因としては、新技術の導入・使用、流通システムの高度化、不適切な生産・製造システム、輸入食品へのアクセスの増加などが挙げられます。腸内細菌検査のアウトソーシングは、食品メーカーのコスト削減に貢献しており、この市場の成長を促しています。

主要項目の内訳
企業タイプ別ティア1：65％、ティア2：20％、ティア3：15
呼称別Cレベル：45％、ディレクターレベル：30％、その他：25
地域別北米：10％、欧州：45％、アジア太平洋地域：25％、南米：5％、その他の地域（RoW）：15％。

本レポートに掲載されている主要プレイヤー

- SGS SA (スイス)
- Eurofins Scientific (ルクセンブルグ)
- Intertek Group plc (英国)
- ビューローベリタス(フランス)
- ALS Limited (オーストラリア)
- TÜV SÜD (ドイツ)
- NEOGEN Corporation (米国)
- Mérieux NutriSciences (米国)
- AsureQuality (ニュージーランド)

調査範囲
本レポートでは、腸管疾患検査市場を、検査対象となる病原体、技術、最終用途、地域に基づいて分類しています。本レポートでは、様々なレベルの分析（競争環境、最終用途分析、企業プロファイル）に焦点を当てています。これらの分析は、腸管疾患検査市場の新興および高成長セグメント、高成長地域、国、政府の取り組み、市場の混乱、ドライバー、阻害要因、機会、および課題に関する基本的な見解をまとめて説明しています。
本レポートを購入する理由
- 腸管疾患検査市場の包括的な概要を把握する。
- 業界のトッププレイヤー、その製品ポートフォリオ、採用している主要戦略に関する幅広い情報を得るため。
- 腸内細菌検査市場が成長している主要な国や地域に関する洞察を得る。

　

ページTOPに戻る


　

Summary

The global market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. Foodborne illnesses have affected socioeconomic development by straining health care systems and trade. The factors fueling the growth of the enteric disease testing market are the implementation of stringent regulations related to contaminant detection, growth in consumer awareness, and humid atmospheric conditions, which are leading to an increase in contamination in food. In order to address enteric disease concerns, caused by foodborne illness, skey players in the various regions will need to further improve upon their food safety monitoring programs.

The food segment is estimated to hold the largest market share in the by end use segment for the enteric disease testing market.
The global food trade has been expanding and providing consumers with access to a wider variety of foods throughout the year. Expanding trade has led to the emergence of food contaminants, bringing diversity of food safety regulations and standards in different countries into focus. Growth in international trade creates the need for global mandates and regulations on food safety, which is a significant factor that drives the market for enteric disease testing.

By technology, the rapid technology segment is projected to account for the fastest market share in enteric disease testing market.

Rapid technology is widely used by various testing companies as it offers various advantages like quick results, greater sensitivity, and reliability, which have enabled manufacturers of assured claims to provide safety and quality in their products. Technological advancements, such as chromatography and spectrometry, witness low adoption in South America and Africa but witness increasing adoption in countries of the Asia Pacific region due to the growing investments from current market leaders.

The meat, poultry and seafood sub-segment within the food end use segment is estimated to hold the largest market share of enteric disease testing market over the forecast period.

Bacterial contamination takes place at all stages of slaughtering, leading to foodborne diseases. Defeathering or skinning is a stage where maximum contamination occurs due to improper handling of animals and unhygienic conditions. Inappropriate equipment cleaning procedures have been responsible for the cross-contamination of products. Thus, the demand for their testing is increasing in meat, poultry, and seafood products
The North American region is estimated to account for the largest market share in the global enteric disease testing market.

The North American region is considered to have one of the most advanced food safety programs, however, it faces major challenges. Several factors affect food safety, these include introduction & use of new technologies, more sophisticated distribution systems, inappropriate production and manufacturing systems, and increased access to imported foods. Outsourcing enteric diseases testing has benefited food producers in cutting down costs and has encouraged the growth of this market.

Break-up of Primaries
 By Company Type: Tier 1: 65%, Tier 2: 20%, and Tier 3: 15%
 By Designation: C-Level – 45%, Director Level – 30%, others- 25%
 By Region: North America – 10%, Europe – 45%, Asia Pacific – 25%, South America – 5%, and Rest of the World (RoW) – 15%.

Leading players profiled in this report

• SGS SA (Switzerland)
• Eurofins Scientific (Luxembourg)
• Intertek Group plc (UK)
• Bureau Veritas (France)
• ALS Limited (Australia)
• TÜV SÜD (Germany)
• NEOGEN Corporation (US)
• Mérieux NutriSciences (US)
• AsureQuality (New Zealand)

Research Coverage
This report segments the enteric disease testing market on the basis of pathogen tested, technology, end use, and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the Enteric disease testing market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.
Reasons to buy this report
• To get a comprehensive overview of the enteric disease testing market
• To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them.
• To gain insights about the major countries/regions, in which the enteric disease testing market is flourishing.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
FIGURE 1 ENTERIC DISEASE TESTING MARKET SEGMENTATION 31
1.3.1 REGIONAL SEGMENTATION 31
1.4 INCLUSIONS & EXCLUSIONS 32
1.4.1 PERIODIZATION CONSIDERED 33
1.5 CURRENCY CONSIDERED 33
TABLE 1 USD EXCHANGE RATES, 2015–2019 34
1.6 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 ENTERIC DISEASE TESTING MARKET: RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
2.1.2.1 Key industry insights 37
2.1.2.2 Breakdown of primary interviews 38
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 39
2.2.1 BOTTOM-UP APPROACH 39
2.2.2 TOP-DOWN APPROACH 39
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY APPROACH 40
2.3 DATA TRIANGULATION 41
FIGURE 5 DATA TRIANGULATION METHODOLOGY 41
2.3.1 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: SUPPLY SIDE 42
FIGURE 6 MARKET SIZE ESTIMATION OF ENTERIC DISEASE TESTING MARKET, 2020 42
2.3.2 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: DEMAND SIDE 42
2.4 RESEARCH ASSUMPTIONS 43
2.5 RESEARCH LIMITATIONS 44
2.6 MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-19 44
2.7 SCENARIO-BASED MODELLING 45
2.8 COVID-19 HEALTH ASSESSMENT 45
FIGURE 7 COVID-19: GLOBAL PROPAGATION 45
FIGURE 8 COVID-19 PROPAGATION: SELECT COUNTRIES 46
2.9 COVID-19 ECONOMIC ASSESSMENT 47
FIGURE 9 REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 2020 47
2.9.1 COVID-19 ECONOMIC IMPACT—SCENARIO ASSESSMENT 48
FIGURE 10 CRITERIA IMPACTING GLOBAL ECONOMY 48
FIGURE 11 SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY 49
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 54
4.1 OPPORTUNITIES IN THE ENTERIC DISEASE TESTING MARKET 54
4.2 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET, BY END USE & COUNTRY 55
4.3 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN 55
FIGURE 18 SALMONELLA TO ACCOUNT FOR THE LARGEST SHARE FOR ENTERIC DISEASE TESTING IN 2020 55
4.4 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY 56
4.5 ENTERIC DISEASE TESTING MARKET IN FOOD, BY REGION & SUBSEGMENT 56
4.6 ENTERIC DISEASE TESTING MARKET: MAJOR REGIONAL SUBMARKETS 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MACROECONOMIC INDICATORS 58
5.2.1 INCREASE IN FOODBORNE ILLNESSES 58
FIGURE 22 NUMBER OF FOODBORNE ILLNESSES ACROSS THE GLOBE, 2020 (MILLION) 59
FIGURE 23 US: TOP FIVE PATHOGENS CONTRIBUTING TO FOODBORNE ILLNESSES, 2020 59
5.3 MARKET DYNAMICS 60
FIGURE 24 ENTERIC DISEASE TESTING MARKET DYNAMICS 60
5.3.1 DRIVERS 60
5.3.1.1 Increase in the number of food recalls 60
FIGURE 25 EU: NUMBER OF FOOD RECALLS, 2017–2020 61
FIGURE 26 US: REASONS FOR RECALL OF FOOD, 2020 61
5.3.1.2 Rise in demand for convenience foods 61
FIGURE 27 READY-TO-EAT FOODS MOST AFFECTED BY FOOD RECALLS, 2020 62
FIGURE 28 RISE IN GLOBAL MEAT EXPORTS, 2017–2020 (KT) 62
5.3.1.3 Increase in global trade owing to higher disposable income among consumers 62
FIGURE 29 GLOBAL AGRI-FOOD EXPORT VALUE, BY KEY COUNTRY, 
2016–2018 (USD BILLION) 63
FIGURE 30 COUNTRY-WISE PREPARED FOODS TRADE SCENARIOS, BY KEY COUNTRY, 2019 (USD MILLION) 63
5.3.2 RESTRAINTS 64
5.3.2.1 Lack of proper regulations governing pathogen testing in the developing economies 64
 
5.3.3 OPPORTUNITIES 64
5.3.3.1 Technological innovations in the food safety testing industry 64
5.3.3.2 R&D investment directed toward the development of PCR technology for improved pathogen testing 64
TABLE 2 R&D INVESTMENT BY MAJOR COMPANIES 65
5.3.4 CHALLENGES 65
5.3.4.1 High cost associated with testing of food and water 65
6 INDUSTRY TRENDS 66
6.1 INTRODUCTION 66
6.2 REGULATORY FRAMEWORK 66
6.2.1 INTRODUCTION 66
6.2.2 INTERNATIONAL BODIES FOR FOOD SAFETY STANDARDS AND REGULATIONS 66
6.2.2.1 Codex Alimentarius Commission (CAC) 66
6.2.2.2 Global Food Safety Initiative (GFSI) 66
6.2.3 NORTH AMERICA 67
6.2.3.1 US regulations 67
6.2.3.2 Mexico 68
6.2.3.3 Canada 68
6.2.4 EUROPE 69
6.2.4.1 Microbiological criteria regulation 70
6.2.4.2 General food law for food safety 70
6.2.4.3 Germany 70
6.2.4.4 UK 71
6.2.4.5 France 71
6.2.4.6 Italy 71
6.2.4.7 Poland 72
6.2.5 ASIA PACIFIC 72
6.2.5.1 China 72
TABLE 3 PATHOGEN LIMITS FOR FOOD 72
6.2.5.2 India 73
6.2.5.3 Japan 74
6.2.5.4 Australia 74
6.2.5.5 New Zealand 75
6.2.6 SOUTH AMERICA 75
6.2.6.1 Brazil 75
6.2.6.2 Ministry of Agriculture, Livestock, and Food Supply (MAPA) 75
6.2.6.3 Ministry of Health (MS) 75
6.2.6.4 Argentina 76
6.3 PORTER’S FIVE FORCES ANALYSIS 77
TABLE 4 ENTERIC DISEASE TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 77
6.3.1 THREAT OF NEW ENTRANTS 77
6.3.2 THREAT OF SUBSTITUTES 77
6.3.3 BARGAINING POWER OF SUPPLIERS 78
6.3.4 BARGAINING POWER OF BUYERS 78
6.3.5 DEGREE OF COMPETITION 78
6.4 MARKET ECOSYSTEM 79
FIGURE 31 ENTERIC DISEASE TESTING MARKET ECOSYSTEM MAP 79
6.4.1 UPSTREAM 79
6.4.2 DOWNSTREAM 79
TABLE 5 COMPANY MARKET ECOSYSTEM 80
6.5 SUPPLY CHAIN ANALYSIS 81
FIGURE 32 REGULATORY BODIES: ENTERIC DISEASE TESTING MARKET 81
6.5.1 R&D 82
6.5.2 PRODUCTION 82
6.5.3 PROCESSING & TRANSFORMING 82
6.5.4 TRANSPORTATION 82
6.5.5 FINAL PREPARATION 82
6.5.6 DISTRIBUTION 82
6.6 TECHNOLOGY ANALYSIS 83
6.7 PATENT ANALYSIS 84
FIGURE 33 PATENT ANALYSIS, 2017-2020 84
TABLE 6 KEY PATENTS FILED IN THE ENTERIC DISEASES TESTING MARKET, 
2018- 2021 85
6.8 CASE STUDIES 85
TABLE 7 AUTOMATED PATHOGEN DETECTION USING VIDAS ADVANCED TESTING SOLUTION 85
6.9 DISRUPTIONS IMPACTING BUYERS IN THE MARKET 86
FIGURE 34 THE DEMAND FOR CONVENIENCE FOODS IS DRIVING THE MARKET FOR ENTERIC DISEASE TESTING IN FROZEN FRUITS & VEGETABLES 86
6.10 IMPACT OF COVID-19 ON MARKET DYNAMICS 86
6.10.1 COVID-19 INCREASED THE DEMAND FOR FOOD SAFETY AND ASSESSMENT 87
6.10.2 COVID-19 HAS SHIFTED THE FOCUS TOWARDS GENERAL HYGIENE SERVICES FROM FOOD SAFETY 87
7 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN 88
7.1 INTRODUCTION 89
FIGURE 35 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 
2021 VS. 2026 (USD MILLION) 89
TABLE 8 PATHOGENESIS OF COMMON PATHOGENS 90
FIGURE 36 US: FOODBORNE DISEASE OUTBREAKS, OUTBREAK-ASSOCIATED ILLNESSES, AND HOSPITALIZATIONS, 2019 90
TABLE 9 US: INCIDENCE OF BACTERIAL AND PARASITIC INFECTIONS, 2019 91
TABLE 10 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 
2016–2020 (USD MILLION) 91
TABLE 11 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 
2021–2026 (USD MILLION) 92
7.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, 
BY PATHOGEN 92
7.1.1.1 Realistic Scenario 92
TABLE 12 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY PATHOGEN, 2016–2020 (USD MILLION) 92
TABLE 13 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY PATHOGEN, 2021–2026 (USD MILLION) 93
7.1.1.2 Optimistic Scenario 93
TABLE 14 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY PATHOGEN, 2016–2020 (USD MILLION) 93
TABLE 15 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY PATHOGEN, 2021–2026 (USD MILLION) 94
7.1.1.3 Pessimistic Scenario 94
TABLE 16 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY PATHOGEN, 2016–2020 (USD MILLION) 94
TABLE 17 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY PATHOGEN, 2021–2026 (USD MILLION) 95
7.1.2 E. COLI 95
7.1.2.1 Proper food safety testing can limit the incidences of E. coli food poisoning 95
FIGURE 37 US: ANNUAL NUMBER OF E. COLI OUTBREAKS, 2009–2018 96
FIGURE 38 TRANSMISSION CYCLE OF ETEC (ENTEROTOXIGENIC E. COLI) 96
TABLE 18 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2016–2020 (USD MILLION) 97
TABLE 19 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2021–2026 (USD MILLION) 97
7.1.3 SALMONELLA 98
7.1.3.1 Salmonella foodborne infection is found to be severe during summer than in winter 98
FIGURE 39 US: SALMONELLA OUTBREAKS, BY NUMBER AND CAUSE, 2009–2018 98
TABLE 20 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2016–2020 (USD MILLION) 98
TABLE 21 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2021–2026 (USD MILLION) 99
7.1.4 CAMPYLOBACTER 99
7.1.4.1 WHO is strengthening disease surveillance to prevent foodborne illness 99
FIGURE 40 US: ANNUAL CAMPYLOBACTER OUTBREAKS, 2009–2018 100
TABLE 22 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2016–2020 (USD MILLION) 100
TABLE 23 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2021–2026 (USD MILLION) 100
7.1.5 LISTERIA 101
7.1.5.1 L. monocytogenes causes high hospitalization rate than any other foodborne pathogen 101
TABLE 24 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2016–2020 (USD MILLION) 101
TABLE 25 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2021–2026 (USD MILLION) 101
7.1.6 OTHER PATHOGENS 102
TABLE 26 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 102
TABLE 27 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 102
8 ENTERIC DISEASE TESTING MARKET, BY END USE 103
8.1 INTRODUCTION 104
FIGURE 41 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF NON-ANIMAL ORIGIN, 2019 104
FIGURE 42 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021 VS. 2026 (USD MILLION) 104
TABLE 28 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 105
TABLE 29 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 105
TABLE 30 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2016–2020 (USD MILLION) 105
TABLE 31 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 
2021–2026 (USD MILLION) 106
8.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY END USE 106
8.1.1.1 Realistic scenario 106
TABLE 32 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2016–2020 (USD MILLION) 106
TABLE 33 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2021–2026 (USD MILLION) 107
8.1.1.2 Optimistic scenario 107
TABLE 34 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
 BY END USE, 2016–2020 (USD MILLION) 107
TABLE 35 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2021–2026 (USD MILLION) 107
8.1.1.3 Pessimistic scenario 108
TABLE 36 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2016–2020 (USD MILLION) 108
TABLE 37 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2021–2026 (USD MILLION) 108
8.2 FOOD 108
8.2.1 MEAT & POULTRY PRODUCTS TO PROVIDE MORE SCOPE FOR FOOD TESTING 108
TABLE 38 ENTERIC DISEASE TESTING MARKET FOR FOOD SOURCE, BY FOODBORNE PATHOGENS 109
FIGURE 43 EU: FOODBORNE DISEASE OUTBREAKS, 2017 110
TABLE 39 EU: OCCURRENCE OF CAMPYLOBACTER IN MAJOR FOOD CATEGORIES 110
TABLE 40 US: FOOD RECALLS, 2020 111
TABLE 41 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 
2016–2020 (USD MILLION) 112
TABLE 42 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 
2021–2026 (USD MILLION) 113
TABLE 43 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 
2016–2020 (USD MILLION) 113
TABLE 44 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 
2021–2026 (USD MILLION) 113
8.2.2 MEAT, POULTRY, AND SEAFOOD 114
8.2.2.1 Unclean slaughterhouses and processing plants are the key contributors to bacterial contamination 114
FIGURE 44 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF ANIMAL ORIGIN, 2019 114
TABLE 45 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2016–2020 (USD MILLION) 115
TABLE 46 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2021–2026 (USD MILLION) 115
TABLE 47 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, 
BY PATHOGEN, 2016–2020 (USD MILLION) 115
TABLE 48 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, 
BY PATHOGEN, 2021–2026 (USD MILLION) 116
8.2.3 DAIRY PRODUCTS 116
8.2.3.1 Unhygienic storage conditions lead to contamination of dairy products 116
FIGURE 45 EU: FREQUENCY DISTRIBUTION OF ILLNESSES IN DAIRY PRODUCTS, 2019 117
TABLE 49 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2016–2020 (USD MILLION) 117
TABLE 50 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2021–2026 (USD MILLION) 117
TABLE 51 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, 
BY PATHOGEN, 2016–2020 (USD MILLION) 118
TABLE 52 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, 
BY PATHOGEN, 2021–2026 (USD MILLION) 118
8.2.4 PROCESSED FOOD 118
8.2.4.1 Ready-To-Eat foods are gaining more traction among consumers 118
TABLE 53 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOOD, BY REGION, 2016–2020 (USD MILLION) 119
TABLE 54 ENTERIC DISEASE TESTING MARKET SIZE FOR PROCESSED FOOD, 
BY REGION, 2021–2026 (USD MILLION) 119
TABLE 55 ENTERIC DISEASE TESTING MARKET IN PROCESSED FOODS, BY PATHOGEN, 2016–2020 (USD MILLION) 120
TABLE 56 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOODS, 
BY PATHOGEN, 2021–2026 (USD MILLION) 120
8.2.5 FRUITS & VEGETABLES 120
8.2.5.1 Good handling practices can help in the safe production of fresh produce 120
TABLE 57 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, 
BY REGION, 2016–2020 (USD MILLION) 121
TABLE 58 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, 
BY REGION, 2021–2026 (USD MILLION) 121
TABLE 59 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, 
BY PATHOGEN, 2016–2020 (USD MILLION) 121
TABLE 60 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, 
BY PATHOGEN, 2021–2026 (USD MILLION) 122
8.2.6 OTHER FOOD APPLICATIONS 122
TABLE 61 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, 
BY REGION, 2016–2020 (USD MILLION) 123
TABLE 62 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, 
BY REGION, 2021–2026 (USD MILLION) 123
TABLE 63 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, 
BY PATHOGEN, 2016–2020 (USD MILLION) 123
TABLE 64 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, 
BY PATHOGEN, 2021–2026 (USD MILLION) 124
8.3 WATER 124
8.3.1 POOR HYGIENIC CONDITIONS LEAD TO WATERBORNE DISEASES IN DEVELOPING REGIONS 124
TABLE 65 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 
2016–2020 (USD MILLION) 124
TABLE 66 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 
2021–2026 (USD MILLION) 125
TABLE 67 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 
2016–2020 (USD MILLION) 125
TABLE 68 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 
2021–2026 (USD MILLION) 125
9 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY 126
9.1 INTRODUCTION 127
FIGURE 46 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 
2021 VS. 2026 (USD MILLION) 127
TABLE 69 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 
2016–2020 (USD MILLION) 127
TABLE 70 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 
2021–2026 (USD MILLION) 128
9.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, 
BY TECHNOLOGY 128
9.1.1.1 Realistic scenario 128
TABLE 71 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY TECHNOLOGY, 2016–2020 (USD MILLION) 128
TABLE 72 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY TECHNOLOGY, 2021–2026 (USD MILLION) 128
9.1.1.2 Optimistic scenario 129
TABLE 73 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY TECHNOLOGY, 2016–2020 (USD MILLION) 129
TABLE 74 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY TECHNOLOGY, 2021–2026 (USD MILLION) 129
9.1.1.3 Pessimistic scenario 129
TABLE 75 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY TECHNOLOGY, 2016–2020 (USD MILLION) 129
TABLE 76 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY TECHNOLOGY, 2021–2026 (USD MILLION) 129
9.2 TRADITIONAL 130
9.2.1 CULTURAL TECHNIQUES HAVE BEEN PREFERRED FOR BOTH READY-TO-EAT FOODS AND FRESH PRODUCE 130
TABLE 77 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 
2016–2020 (USD MILLION) 130
TABLE 78 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 
2021–2026 (USD MILLION) 131
9.3 RAPID 131
TABLE 79 ENTERIC DISEASE TESTING MARKET SIZE FOR RAPID TECHNOLOGY, 
BY REGION, 2016–2020 (USD MILLION) 132
TABLE 80 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 
2021–2026 (USD MILLION) 132
TABLE 81 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 
2016–2020 (USD MILLION) 132
TABLE 82 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 
2021–2026 (USD MILLION) 133
9.3.1 CONVENIENCE-BASED 133
9.3.1.1 Helps detect microorganisms based on their biochemical reactions under standard growth conditions 133
9.3.2 POLYMERASE CHAIN REACTION (PCR) 133
9.3.2.1 Real-time PCR involves fluorescent ethidium bromide monoazide dye that prevent the detection of dead organisms 133
9.3.3 IMMUNOASSAY 134
9.3.3.1 ELISA is based on the protein’s characteristic of binding to specific enzyme-labeled antibodies 134
9.3.4 CHROMATOGRAPHY & SPECTROMETRY 135
9.3.4.1 Inductively Coupled Plasma (ICP) is one of the major advancements of mass spectrometry 135
10 ENTERIC DISEASE TESTING MARKET, BY REGION 136
10.1 INTRODUCTION 137
FIGURE 47 REGION-WISE FOOD SAFETY EVENTS, 2020 137
FIGURE 48 US ESTIMATED TO GROW AT THE HIGHEST GROWTH RATE IN THE ENTERIC DISEASE TESTING MARKET, 2021–2026 138
TABLE 83 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 
2016–2020 (USD MILLION) 138
TABLE 84 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 
2021–2026 (USD MILLION) 139
10.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY REGION 139
10.1.1.1 Realistic scenario 139
TABLE 85 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION) 139
TABLE 86 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION) 140
10.1.1.2 Optimistic scenario 140
TABLE 87 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY REGION, 2016–2020 (USD MILLION) 140
TABLE 88 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY REGION, 2021–2026 (USD MILLION) 140
10.1.1.3 Pessimistic scenario 141
TABLE 89 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY REGION, 2016–2020 (USD MILLION) 141
TABLE 90 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, 
BY REGION, 2021–2026 (USD MILLION) 141
10.2 NORTH AMERICA 141
FIGURE 49 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020 142
TABLE 91 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION) 143
TABLE 92 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION) 143
TABLE 93 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION) 143
TABLE 94 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION) 144
TABLE 95 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 144
TABLE 96 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 144
10.2.1 US 145
10.2.1.1 FSIS is the regulating body that enforces food safety regulations 145
FIGURE 50 NUMBER OF DEATHS RELATED TO CONFIRMED INFECTIONS, BY PATHOGEN, 2010–2018 145
FIGURE 51 US: FOODBORNE PATHOGEN INCIDENCE RATE PER 100,000 PERSONS, 2010–2016 146
TABLE 97 US: ESTIMATED EFFECTS OF FOODBORNE AGENTS (2016) 146
FIGURE 52 US: INCIDENCES RELATED TO THE TOP FIVE FOODBORNE PATHOGENS, 2016 147
TABLE 98 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 147
TABLE 99 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 148
TABLE 100 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 148
TABLE 101 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 148
10.2.2 CANADA 149
10.2.2.1 Canadian government imposed stringent regulations on exports to ensure food safety 149
TABLE 102 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 149
TABLE 103 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 149
TABLE 104 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 150
TABLE 105 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 150
10.2.3 MEXICO 151
10.2.3.1 Rise in the number of foodborne disease cases has increased focus on food safety in the country 151
TABLE 106 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 151
TABLE 107 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 151
TABLE 108 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 152
TABLE 109 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 152
10.3 EUROPE 152
FIGURE 53 EU/EEA: DISTRIBUTION OF CONFIRMED CAMPYLOBACTERIOSIS CASES 
AND RATES PER 100 000 POPULATION BY YEAR AND COUNTRY, 2013–2017 153
FIGURE 54 EUROPE: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020 154
TABLE 110 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 
2016–2020 (USD MILLION) 155
TABLE 111 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 
2021–2026 (USD MILLION) 155
TABLE 112 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 156
TABLE 113 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 156
TABLE 114 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 156
TABLE 115 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 157
10.3.1 GERMANY 157
10.3.1.1 International food trade has increased food safety risks 157
FIGURE 55 GERMANY: ACTIVE FOOD TESTING CARRIED OUT FOR VARIOUS FOOD PATHOGENS IN MULTIPLE FOOD PRODUCTS, 2019 158
TABLE 116 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 158
TABLE 117 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 159
TABLE 118 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 159
TABLE 119 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 159
10.3.2 FRANCE 160
10.3.2.1 Large number of foodborne outbreaks in meat-based food encouraging the growth of enteric disease testing 160
TABLE 120 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 160
TABLE 121 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 160
TABLE 122 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 161
TABLE 123 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 161
10.3.3 SPAIN 161
10.3.3.1 Outbreak of listeriosis will have serious implications on the Spanish meat industry 161
TABLE 124 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 162
TABLE 125 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 162
TABLE 126 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 162
TABLE 127 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 163
10.3.4 ITALY 163
10.3.4.1 Products of animal origin products are found to be more problematic in this region 163
TABLE 128 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 163
TABLE 129 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 164
TABLE 130 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 164
TABLE 131 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 164
10.3.5 POLAND 165
10.3.5.1 Increase in incidences of Salmonella outbreaks drives awareness about food safety 165
TABLE 132 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 165
TABLE 133 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 165
TABLE 134 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENTS, 2016–2020 (USD MILLION) 166
TABLE 135 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 166
10.3.6 UK 167
10.3.6.1 Norovirus infection is estimated to occur every year in the UK 167
TABLE 136 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 167
TABLE 137 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 167
TABLE 138 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 167
TABLE 139 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 168
10.3.7 REST OF EUROPE 168
TABLE 140 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION) 168
TABLE 141 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION) 169
TABLE 142 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 169
TABLE 143 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 169
10.4 ASIA PACIFIC 170
TABLE 144 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, 
BY COUNTRY/REGION, 2016–2020 (USD MILLION) 170
TABLE 145 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, 
BY COUNTRY/REGION, 2021–2026 (USD MILLION) 170
TABLE 146 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 171
TABLE 147 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 171
TABLE 148 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 171
TABLE 149 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 172
10.4.1 JAPAN 172
10.4.1.1 E. coli to be the major pathogen found to affect people 172
TABLE 150 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 172
TABLE 151 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 173
TABLE 152 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 173
TABLE 153 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 173
10.4.2 CHINA 174
10.4.2.1 Microbial contamination is reported to be the biggest food safety risk 174
TABLE 154 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 174
TABLE 155 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 174
TABLE 156 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 175
TABLE 157 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 175
10.4.3 INDIA 175
10.4.3.1 FSSAI to safeguard the quality of food produced 175
TABLE 158 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 176
TABLE 159 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 176
TABLE 160 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 176
TABLE 161 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 177
10.4.4 AUSTRALIA & NEW ZEALAND 177
10.4.4.1 Gastroenteritis occurs every year, affecting several people 177
TABLE 162 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2016–2020 (USD MILLION) 177
TABLE 163 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2021–2026 (USD MILLION) 178
TABLE 164 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 178
TABLE 165 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 178
10.4.5 THAILAND 179
10.4.5.1 Demand for food exports to boost the growth of the market 179
TABLE 166 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 179
TABLE 167 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 179
TABLE 168 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 180
TABLE 169 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 180
10.4.6 REST OF ASIA PACIFIC 180
TABLE 170 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2016–2020 (USD MILLION) 181
TABLE 171 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2021–2026 (USD MILLION) 181
TABLE 172 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 181
TABLE 173 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 182
10.5 SOUTH AMERICA 182
TABLE 174 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION) 182
TABLE 175 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION) 183
TABLE 176 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION) 183
TABLE 177 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION) 183
TABLE 178 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET FOR FOOD END USE, BY SUBSEGMENT,2016–2020 (USD MILLION) 184
TABLE 179 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 184
10.5.1 BRAZIL 184
10.5.1.1 Export of agricultural produce to boost the demand for enteric disease testing 184
TABLE 180 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 185
TABLE 181 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 185
TABLE 182 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 185
TABLE 183 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 186
10.5.2 ARGENTINA 186
10.5.2.1 Food companies are taking preventive measures for pathogen infections 186
TABLE 184 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 186
TABLE 185 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 187
TABLE 186 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 187
TABLE 187 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 187
10.5.3 REST OF SOUTH AMERICA 188
TABLE 188 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2016–2020 (USD MILLION) 188
TABLE 189 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2021–2026 (USD MILLION) 188
TABLE 190 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 188
TABLE 191 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 189
10.6 REST OF THE WORLD (ROW) 189
TABLE 192 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION) 189
TABLE 193 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION) 190
TABLE 194 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 190
TABLE 195 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 190
TABLE 196 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 190
TABLE 197 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 191
10.6.1 SOUTH AFRICA 191
10.6.1.1 Growth in the demand to follow international standards is encouraging enteric disease testing 191
TABLE 198 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2016–2020 (USD MILLION) 191
TABLE 199 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, 
BY END USE, 2021–2026 (USD MILLION) 192
TABLE 200 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 192
TABLE 201 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 192
10.6.2 MIDDLE EAST 193
10.6.2.1 Food safety services are driven by food imports from other countries 193
TABLE 202 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2016–2020 (USD MILLION) 193
TABLE 203 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 
2021–2026 (USD MILLION) 193
TABLE 204 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2016–2020 (USD MILLION) 194
TABLE 205 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, 
BY SUBSEGMENT, 2021–2026 (USD MILLION) 194
11 COMPETITIVE LANDSCAPE 195
11.1 OVERVIEW 195
11.2 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE ENTERIC DISEASES TESTING MARKET 196
11.3 MARKET SHARE ANALYSIS, 2020 197
FIGURE 56 MARKET SHARE OBTAINED BY DOMINANT AND OTHER PLAYERS 197
11.4 COVID-19-SPECIFIC COMPANY RESPONSE 198
11.4.1 SGS SA 198
11.4.2 MERCK KGAA 198
11.4.3 EUROFINS SCIENTIFIC 198
11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 198
11.5.1 STARS 199
11.5.2 EMERGING LEADERS 199
11.5.3 PERVASIVE PLAYERS 199
11.5.4 PARTICIPANTS 199
FIGURE 57 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (KEY PLAYERS) 200
11.6 PRODUCT FOOTPRINT 201
TABLE 206 COMPANY FOOTPRINT, BY TECHNOLOGY 201
TABLE 207 COMPANY FOOTPRINT, BY END-USE 202
TABLE 208 COMPANY FOOTPRINT, BY REGION 203
11.7 COMPANY EVALUATION QUADRANT (START-UP/SME) 204
11.7.1 PROGRESSIVE COMPANIES 204
11.7.2 STARTING BLOCKS 204
11.7.3 RESPONSIVE COMPANIES 204
11.7.4 DYNAMIC COMPANIES 204
FIGURE 58 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (START-UPS/SME) 205
11.8 COMPETITIVE SCENARIO 205
11.8.1 NEW PRODUCTS LAUNCHES 205
TABLE 209 ENTERIC DISEASE TESTING MARKET: NEW PRODUCT LAUNCHES, JULY 2019 205
11.8.2 DEALS 206
TABLE 210 ENTERIC DISEASE TESTING MARKET: DEALS, MAY 2017- JULY 2021 206
11.8.3 OTHER DEVELOPMENTS 207
TABLE 211 ENTERIC DISEASE TESTING MARKET: OTHER DEVELOPMENTS, 
MAY 2018- JUNE 2021 207
12 COMPANY PROFILES 208
(Business overview, Products offered, Recent developments & MnM View)*
12.1 KEY COMPANIES 208
12.1.1 SGS SA 208
TABLE 212 SGS SA: BUSINESS OVERVIEW 208
FIGURE 59 SGS SA: COMPANY SNAPSHOT 209
TABLE 213 SGS SA: PRODUCT OFFERINGS 209
TABLE 214 SGA SA: DEALS 210
TABLE 215 SGS SA: OTHERS 210
12.1.2 MERCK KGAA 212
TABLE 216 MERCK KGAA: BUSINESS OVERVIEW 212
FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT 213
TABLE 217 MERCK KGAA: PRODUCT OFFERINGS 213
12.1.3 THERMO FISHER SCIENTIFIC INC. 215
TABLE 218 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 215
FIGURE 61 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 216
TABLE 219 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 216
TABLE 220 THERMO FISHER SCIENTIFIC INC.: DEALS 218
12.1.4 EUROFINS SCIENTIFIC 219
TABLE 221 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 219
FIGURE 62 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT 220
TABLE 222 EUROFINS SCIENTIFIC: PRODUCT OFFERINGS 220
TABLE 223 EUROFINS SCIENTIFIC: DEALS 221
TABLE 224 EUROFINS SCIENTIFIC: OTHER DEVELOPMENTS 222
12.1.5 ALS LIMITED 223
TABLE 225 ALS LIMITED: BUSINESS OVERVIEW 223
FIGURE 63 ALS LIMITED: COMPANY SNAPSHOT 223
TABLE 226 ALS LIMITED: PRODUCT OFFERINGS 224
TABLE 227 ALS LIMITED: DEALS 224
TABLE 228 ALS LIMITED: OTHER DEVELOPMENTS 225
12.1.6 ASURE QUALITY 226
TABLE 229 ASURE QUALITY: BUSINESS OVERVIEW 226
FIGURE 64 ASURE QUALITY: COMPANY SNAPSHOT 226
TABLE 230 ASURE QUALITY: PRODUCT OFFERINGS 227
12.1.7 BUREAU VERITAS 228
TABLE 231 BUREAU VERITAS: BUSINESS OVERVIEW 228
FIGURE 65 BUREAU VERITAS: COMPANY SNAPSHOT 229
TABLE 232 BUREAU VERITAS: PRODUCT OFFERINGS 229
12.1.8 INTERTEK 231
TABLE 233 INTERTEK: BUSINESS OVERVIEW 231
FIGURE 66 INTERTEK: COMPANY SNAPSHOT 232
TABLE 234 INTERTEK: PRODUCT OFFERINGS 232
TABLE 235 INTERTEK: DEALS 233
12.1.9 BIO-RAD LABORATORIES, INC. 234
TABLE 236 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 234
FIGURE 67 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 234
TABLE 237 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS 235
12.1.10 BECTON DICKINSON 237
TABLE 238 BECTON DICKINSON: BUSINESS OVERVIEW 237
FIGURE 68 BECTON DICKINSON: COMPANY SNAPSHOT 238
TABLE 239 BECTON DICKINSON: PRODUCT OFFERINGS 238
12.1.11 3M 240
TABLE 240 3M: BUSINESS OVERVIEW 240
FIGURE 69 3M: COMPANY SNAPSHOT 240
TABLE 241 3M: PRODUCT OFFERINGS 241
12.1.12 PERKINELMER, INC. 242
TABLE 242 PERKINELMER, INC.: BUSINESS OVERVIEW 242
FIGURE 70 PERKINELMER, INC.: COMPANY SNAPSHOT 243
TABLE 243 PERKINELMER, INC.: PRODUCT OFFERINGS 244
12.1.13 NEOGEN CORPORATION 245
TABLE 244 NEOGEN CORPORATION: BUSINESS OVERVIEW 245
FIGURE 71 NEOGEN CORPORATION: COMPANY SNAPSHOT 245
TABLE 245 NEOGEN CORPORATION: PRODUCT OFFERINGS 246
12.1.14 MÉRIEUX NUTRISCIENCES 248
TABLE 246 MÉRIEUX NUTRISCIENCES: BUSINESS OVERVIEW 248
TABLE 247 MÉRIEUX NUTRISCIENCES: PRODUCT OFFERINGS 248
TABLE 248 MÉRIEUX NUTRISCIENCES: DEALS 249
12.1.15 TÜV SÜD 250
TABLE 249 TÜV SÜD: BUSINESS OVERVIEW 250
TABLE 250 TÜV SÜD: PRODUCT OFFERINGS 250
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
 
12.2 OTHER PLAYERS 251
12.2.1 HARDY DIAGNOSTICS 251
TABLE 251 HARDY DIAGNOSTICS: BUSINESS OVERVIEW 251
TABLE 252 HARDY DIAGNOSTICS: PRODUCT OFFERINGS 251
TABLE 253 HARDY DIAGNOSTICS: NEW PRODUCT LAUNCH 252
12.2.2 ROMER LABS 253
TABLE 254 ROMER LABS: BUSINESS OVERVIEW 253
TABLE 255 ROMER LABS: PRODUCT OFFERINGS 253
12.2.3 NOVA BIOLOGICALS 254
TABLE 256 NOVA BIOLOGICALS: BUSINESS OVERVIEW 254
TABLE 257 NOVA BIOLOGICALS: PRODUCT OFFERINGS 254
12.2.4 SYMBIO LABORATORIES 255
TABLE 258 SYMBIO LABORATORIES: BUSINESS OVERVIEW 255
TABLE 259 SYMBIO LABORATORIES: PRODUCT OFFERINGS 255
12.2.5 CERTIFIED LABORATORIES 256
13 ADJACENT AND RELATED MARKETS 257
13.1 INTRODUCTION 257
TABLE 260 ADJACENT MARKETS TO ENTERIC DISEASE TESTING MARKET 257
13.2 LIMITATIONS 257
13.3 FOOD PATHOGEN TESTING MARKET 257
13.3.1 MARKET DEFINITION 257
13.3.2 MARKET OVERVIEW 258
TABLE 261 E. COLI MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 259
TABLE 262 SALMONELLA MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 259
TABLE 263 CAMPYLOBACTER MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 259
TABLE 264 LISTERIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 260
13.4 FOOD TESTING KITS MARKET 260
13.4.1 MARKET DEFINITION 260
13.4.2 MARKET OVERVIEW 260
TABLE 265 FOOD TESTING KITS MARKET SIZE IN MEAT, POULTRY, 
AND SEAFOOD PRODUCTS, BY REGION, 2015–2022 (USD MILLION) 261
TABLE 266 FOOD TESTING KITS MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 
2015–2022 (USD MILLION) 261
TABLE 267 FOOD TESTING KITS MARKET SIZE IN PROCESSED FOOD, BY REGION, 
2015–2022 (USD MILLION) 261
TABLE 268 FOOD TESTING KITS MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2015–2022 (USD MILLION) 262
 
13.5 MICROBIAL WATER TESTING MARKET 262
13.5.1 MARKET DEFINITION 262
13.5.2 MARKET OVERVIEW 263
TABLE 269 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY WATER TYPE, 2015–2022 (USD MILLION) 263
TABLE 270 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 
2015–2022 (USD MILLION) 263
TABLE 271 DRINKING & BOTTLED MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 264
TABLE 272 INDUSTRIAL MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 264
14 APPENDIX 265
14.1 DISCUSSION GUIDE 265
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 269
14.3 AVAILABLE CUSTOMIZATIONS 271
14.4 RELATED REPORTS 272
14.5 AUTHOR DETAILS 273

 

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/18　10:26

155.35 円

164.28 円

199.02 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.